With better intellectual property rights abroad and high percentage rates for depreciation, lower cost for materials, and decreased wait times for access to patients, the global landscape for pharmaceutical outsourcing is maturing. However, entering new countries for outsourcing endeavors can increase risk; Alsbridge minimizes this risk based on experience, innovation, and quality of deliverables.
Prescription and non-prescription entities, mergers and acquisitions, and patent expirations are not new terms to us. We’ve assisted several pharmaceutical and bio-technology companies to help them achieve outsourcing solutions using our innovative, collaborative, and proven methodology. Your business is competitive from the Investigational New Drug Application (INDA) to the approval process. Your process must be mature and ubiquitous.
Aligning your IT organization with the contract research organizations either domestically or internationally in an outsourcing agreement can be a mixed bag. We've worked with many fragmented organizations that align IT outsourcing agreements to the meet the demanding needs of this industry by using a proven and innovative process that designs agreements for a tailored fit.